Campbell David Alan bought JANX
July 8, 2026 · Form 4 insider transaction
Campbell David Alan bought 7,000 shares of Janux Therapeutics, Inc. at $4.21 per share, a transaction worth $29.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,000
Price
$4.21
Total value
$29.5K
InsiderCampbell David Alan
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 8, 2026
Filing dateJuly 10, 2026
Shares owned after388,582
OwnershipDirect
10b5-1 planNo
AmendedNo